Clinical features and CKD-related quality of life in patients with CKD G3a and CKD G3b in China: results from the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE)

[1]  Hong Zhang,et al.  Dividing CKD stage 3 into G3a and G3b could better predict the prognosis of IgA nephropathy , 2017, PloS one.

[2]  J. Coresh,et al.  The public health dimension of chronic kidney disease: what we have learnt over the past decade: Clinical Epidemiology in Nephrology , 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  Ming-hui Zhao,et al.  Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE) , 2017, BMC Nephrology.

[4]  J. Coresh,et al.  Trends in Chronic Kidney Disease in China. , 2016, The New England journal of medicine.

[5]  Hong Yuan,et al.  Chronic kidney disease among overweight and obesity with and without metabolic syndrome in an urban Chinese cohort , 2015, BMC Nephrology.

[6]  S. Chow,et al.  Is the kidney disease quality of life-36 (KDQOL-36) a valid instrument for Chinese dialysis patients? , 2014, BMC Nephrology.

[7]  Xingjuan Tao,et al.  Determining the validity and reliability of the Chinese version of the Kidney Disease Quality of Life Questionnaire (KDQOL-36™) , 2014, BMC Nephrology.

[8]  H. Morgenstern,et al.  Recovery time, quality of life, and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  Luxia Zhang,et al.  Chinese cohort study of chronic kidney disease: design and methods , 2014, Chinese medical journal.

[10]  Kaleab Z. Abebe,et al.  Health-related quality of life in patients with autosomal dominant polycystic kidney disease and CKD stages 1-4: a cross-sectional study. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[11]  Desmond E. Williams,et al.  Medical costs of CKD in the Medicare population. , 2013, Journal of the American Society of Nephrology : JASN.

[12]  V. Jha,et al.  Chronic kidney disease: global dimension and perspectives , 2013, The Lancet.

[13]  G. Remuzzi,et al.  Mechanisms and treatment of CKD. , 2012, Journal of the American Society of Nephrology : JASN.

[14]  M. Mifune,et al.  The usefulness of the revised classification for chronic kidney disease by the KDIGO for determining the frequency of diabetic micro- and macroangiopathies in Japanese patients with type 2 diabetes mellitus. , 2012, Journal of diabetes and its complications.

[15]  Nan Chen,et al.  Prevalence of chronic kidney disease in China: a cross-sectional survey , 2012, The Lancet.

[16]  Bertram L Kasiske,et al.  The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. , 2011, Kidney international.

[17]  S. Hallan,et al.  The Conundrum of Chronic Kidney Disease Classification and End-Stage Renal Risk Prediction in the Elderly – What Is the Right Approach? , 2010, Nephron Clinical Practice.

[18]  Luxia Zhang,et al.  Chronic kidney disease epidemic: cost and health care implications in China. , 2009, Seminars in nephrology.

[19]  S. Weisbord,et al.  Symptom burden, depression, and quality of life in chronic and end-stage kidney disease. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[20]  Stian Lydersen,et al.  Combining GFR and albuminuria to classify CKD improves prediction of ESRD. , 2009, Journal of the American Society of Nephrology : JASN.

[21]  D. Chae,et al.  Moderately decreased renal function negatively affects the health-related quality of life among the elderly Korean population: a population-based study. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  N. Abutaleb.  Why we should sub-divide CKD stage 3 into early (3a) and late (3b) components. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  Stefanos Zenios,et al.  Health-related quality of life and estimates of utility in chronic kidney disease. , 2005, Kidney international.

[24]  A. Murray,et al.  Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. , 2005, Journal of the American Society of Nephrology : JASN.

[25]  E. Lowrie,et al.  Medical outcomes study short form-36: a consistent and powerful predictor of morbidity and mortality in dialysis patients. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[26]  P. Kimmel,et al.  New clinical practice guidelines for chronic kidney disease: a framework for K/DOQI. , 2002, Seminars in nephrology.

[27]  P. Deoreo,et al.  Hemodialysis patient-assessed functional health status predicts continued survival, hospitalization, and dialysis-attendance compliance. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[28]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.